(Acute Myeloid Leukemia OR Leukemia, Acute Myelogenous OR Leukemia, Myeloblastic, Acute OR Leukemia, Myelocytic, Acute OR Leukemia, Myelogenous, Acute OR Leukemia, Nonlymphoblastic, Acute OR Leukemia, Nonlymphocytic, Acute OR AML) AND (genetic mutation OR chromosome aberrations OR chromosome abnormalities OR mutation* OR Core Binding Factor alpha Proteins OR Runx Proteins OR Polyomavirus Enhancer A Binding Protein 2 OR Polyomavirus Enhancer Binding Protein 2, Alpha Subunit OR Runt Domain Factor OR Acute Myeloid Leukemia Proteins OR PEBP2A Transcription Factors OR Transcription Factors, PEBP2A OR CEBPA OR t(8:21) OR t(16) OR inv(16) OR inv(16) fusion protein, human OR NPM1 OR FLT3) AND random* = 73 |